[1,4'-Bipiperidine]-1'-carbonyl chloride

Catalog No. :
ACJHZY726
CAS No. :
103816-19-9
Molecular Formula :
C11H19ClN2O
Molecular Weight :
230.74

IUPAC Name:[1,4'-bipiperidine]-1'-carbonyl chloride

[1,4'-Bipiperidine]-1'-carbonyl chloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$55.00Login to see priceIn stockInquiry
5g98%$190.00Login to see priceIn stockInquiry
25g98%$661.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name[1,4'-Bipiperidine]-1'-carbonyl chloride
IUPAC Name[1,4'-bipiperidine]-1'-carbonyl chloride
MDL No.MFCD08445612
Molecular FormulaC11H19ClN2O
Molecular Weight230.74
SMILESO=C(Cl)N1CCC(N2CCCCC2)CC1
InChI KeyYDNSNQRKIINKPV-UHFFFAOYSA-N
Synonym1-CHLOROCARBONYL-4-PIPERIDINOPERIDINE;forMyl[4-(piperidin-1-yl)piperidin-1-yl]chloranuide;4-Piperidinopiperidine-1-carbonyl chloride;4-Piperidinopiperidine-1-carbonyl chloride;Irinotecan Impurity 23;4-PIPERIDINOPIPERIDINE-1-CARBONYL CHLOR&;1,4'-Bipiperidine]-1'-carbonyl chloride (9CI, ACI);4-piperidylpiperidinecarbonyl chloride
CAS No.103816-19-9
PubChem CID9813375

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H312-H314-H332
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACJHZY726 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOLKA402 route compound structure diagram
    ACOLKA4024897-50-1 In Stock
  2. Then
  3. ACJHZY726 route product structure diagram
    ACJHZY726103816-19-9 In Stock
Inquiry

2. ACJHZY726 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOLKA402 route compound structure diagram
    ACOLKA4024897-50-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJHZY726 route product structure diagram
    ACJHZY726103816-19-9 In Stock
Inquiry

Comments (0)